Cosmetic cross-reference Noindex: medium evidence

22047-49-0

CAS 22047-49-0

22047-49-0 (CAS 22047-49-0) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
22047-49-0
CAS Number
22047-49-0
UNII
EG3PA2K3K5
InChIKey
OPJWPPVYCOPDCM-UHFFFAOYSA-N
ChEMBL ID
CHEMBL3184927
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
Synonyms and normalized names
ETHYLHEXYL STEARATE
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE NLM RxNorm 1 name row

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
ETHYLHEXYL STEARATE 1369682 SU MTHSPL
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is 22047-49-0 used for in pharmaceutical contexts?

22047-49-0 (CAS 22047-49-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for 22047-49-0?

No adverse-event association or SIDER side-effect rows are rendered for 22047-49-0 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is 22047-49-0 also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Ethylhexyl Stearate with EU status "permitted".

What clinical phase is 22047-49-0 in?

No phase 1-4 clinical development badge is rendered for 22047-49-0 because the matched compound identifier rows do not contain a max-phase value.